These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25197349)

  • 21. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
    Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer.
    Ren J; Xu S; Guo D; Zhang J; Liu S
    Clin Transl Oncol; 2014 Jul; 16(7):668-74. PubMed ID: 24248895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer.
    Ke B; Wu LL; Liu N; Zhang RP; Wang CL; Liang H
    Tumour Biol; 2013 Oct; 34(5):3137-45. PubMed ID: 23760979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
    Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
    Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
    Fujimoto D; Goi T; Hirono Y
    Int J Oncol; 2017 Feb; 50(2):448-456. PubMed ID: 28035352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lin28B is a novel prognostic marker in gastric adenocarcinoma.
    Hu Q; Peng J; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Liu S; Wang H
    Int J Clin Exp Pathol; 2014; 7(8):5083-92. PubMed ID: 25197381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population.
    Lu X; Cheng C; Zhu S; Yang Y; Zheng L; Wang G; Shu X; Wu K; Liu K; Tong Q
    Oncol Rep; 2010 Oct; 24(4):981-7. PubMed ID: 20811679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological correlation and prognostic significance of sonic hedgehog protein overexpression in human gastric cancer.
    Niu Y; Li F; Tang B; Shi Y; Hao Y; Yu P
    Int J Clin Exp Pathol; 2014; 7(8):5144-53. PubMed ID: 25197388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
    Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
    Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
    Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of C/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance.
    Zhu XJ; Gao SG; Li SQ; Shi ZG; Ma ZK; Zhu SS; Feng XS
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):391-8. PubMed ID: 25582300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
    Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
    Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
    Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
    Müller MW; Giese NA; Swiercz JM; Ceyhan GO; Esposito I; Hinz U; Büchler P; Giese T; Büchler MW; Offermanns S; Friess H
    Int J Cancer; 2007 Dec; 121(11):2421-33. PubMed ID: 17631638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.